PENBRAYA Trademark

Trademark Overview


On Thursday, October 6, 2022, a trademark application was filed for PENBRAYA with the United States Patent and Trademark Office. The USPTO has given the PENBRAYA trademark a serial number of 97621374. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Thursday, April 4, 2024. This trademark is owned by Pfizer Inc.. The PENBRAYA trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
penbraya

General Information


Serial Number97621374
Word MarkPENBRAYA
Filing DateThursday, October 6, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateThursday, April 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 22, 2023

Trademark Statements


Goods and ServicesVaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 11, 2022
Primary Code005
First Use Anywhere DateMonday, January 15, 2024
First Use In Commerce DateMonday, January 15, 2024

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-219

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Trademark Events


Event DateEvent Description
Friday, April 5, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, April 4, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 3, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 13, 2024USE AMENDMENT FILED
Wednesday, April 3, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 13, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, October 17, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 22, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 22, 2023PUBLISHED FOR OPPOSITION
Wednesday, August 2, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 7, 2023ASSIGNED TO EXAMINER
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 10, 2022NEW APPLICATION ENTERED

Related Keywords


penbraya human vaccines